Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Biolytic Lab Performance Inc. Launches the Dr. Oligo Synthesizer Platform: The World's Fastest and Most Efficient High Throughput DNA, RNA, Oligonucleotide Synthesizer
  • USA - English


News provided by

Biolytic Lab Performance Inc.

Apr 03, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Oligo Synthesizer
Dr. Oligo Synthesizer

Fremont, CA (PRWEB) April 03, 2014 -- World's Fastest High Throughput Synthesis

Boasting a total of 23 amidite delivery systems with up to 19 capable of low volume, 192 oligos can be synthesized as 20 bases in as little as 2 hours. The overall synthesis time can be further cut by up to 35%**** when enabling the double reagent dispensing option. This increases reagent delivery to up to 16 columns simultaneously allowing a 768 oligo synthesis run to be achieved in only 4 hours*.

Ultra Efficient in Reagent and Gas Consumption

"Our main approach has been a focus on innovations which utilize lower quantities of reagent while maintaining a standard for producing high quality oligos,” said Tom Demmitt, President and Founder of Biolytic Lab Performance Inc.

Post this

Without sacrificing on the synthesis quality, the Dr. Oligo Synthesizer keeps operating costs down. A smaller gas chamber maintains up to an 80%***** reduction in gas spent while also taking considerably less time to pressurize. An additional bottle per reagent can be added to allow a bottle to run completely empty before being changed without having to re-prime the lines. Reagent flow rate through the synthesis media (columns) can be fine-tuned with up to three different pressure settings minimizing reagent consumption to achieve optimal synthesis. The optional low volume delivery system minimizes waste of expensive amidites by placing the valves and bottles on the nozzle plate thereby reducing the tubing for priming and delivery.

Key Features of the Dr. Oligo Synthesizer

Fastest High Throughput Synthesis
• 1 to 768 oligos synthesized in one run
• Synthesize 768 oligos in as low as 4 hours* and 192 oligos in 2 1/2 hours******

Ultimate Efficiency
• Three Pressure Levels — Fine tune reagent flow
• Two Bottles Per Reagent — Changing bottles without repriming lines
• Compact Gas Chamber — Up to an 80%**** reduction in gas consumption
• Low Volume Delivery System — Minimizes waste of expensive amidites

Dr. Oligo 5.0 Software
• View synthesis information at any time during synthesis
• Start synthesis from any point
• Auto adjust reagent delivery according to scale of synthesis
• Powerful protocol editor
• Manual mode auto clean of nozzles
• Vary protocol based on cycle
• Intelligent automated reprime of amidite nozzles
• LABS management system compatible

Automated Synthesis and Media Flexibility
• Synthesize, cleave, deprotect**, desalt, and elute all on one instrument
• Designed to allow use of all available synthesis media systems

Superior Build Quality and Fully Upgradeable
• Black anodized aluminum frame provides a sturdy and durable foundation
• Power coated cart and HDPE liner prevents corrosion from harsh chemicals
• Open design allows for existing or future upgrades

*- 12 minutes per cycle at 20 mers with double reagent dispensing option
**- According to Biolytic research as of January 2014
***- A de-protection chemistry at room temperature is required and reagents used must be compatible with the synthesis media
****- For any synthesis run with over 192 oligos
*****- Over leading competitors
****** - 7 minutes per cycle at 20 mers

About Biolytic Lab Performance Inc.

Biolytic® Lab Performance, Inc. designs, manufactures and sells the most advanced oligo synthesizers in the world. Founded in 1993 by four of the leading experts in the biotech instrument service industry, Biolytic continues to provide superior quality, innovative products and esteemed services that push the limits of research and technology.

For more information, please visit http://www.biolytic.com.

Steve Demmitt, Biolytic Lab Performance Inc., http://www.biolytic.com, +1 (510) 795-1142, [email protected]

Modal title

Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer
Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer Dr. Oligo Synthesizer

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.